跳至主要内容
临床试验/NL-OMON21659
NL-OMON21659尚未招募不适用

Evaluation of the relationship between AGEs and treatmentresponsiveness of anti-VEGF in DME patients’

GSMS0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
GSMS
入组人数
70

研究概览

简要总结

A

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients diagnosed with DME who started inravitreal anti-VEGF therapy less than 1 yr ago
  • · Age: >18 years.

排除标准

  • Dark coloured skin (Fitzpatrick type V or VI).
  • · Skin abnormalities on both arms that will impair the reliability of the autofluorescence
  • measurement.
  • · Local or general active infection or inflammatory disease.
  • · Known renal disease, current dialysis treatment, or a history of renal transplantation.
  • · Patients with high myopia (>6 diopters), glaucoma, combined retinal disease, media
  • opacities interfering with OCT imaging, vitreomacular traction on SD-OCT and those
  • whose SD-OCT images were of poor quality, intraocular surgery within 12 weeks prior
  • to the first injection

研究者

发起方
GSMS

相似试验